ArticleTranslational vision science & technology2026
Intrinsic Capacity, Polygenic Risk Score, and Risk of Glaucoma.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to investigate the prospective association between intrinsic capacity (IC) and the risk of incident glaucoma. Methods: We performed prospective cohort analyses among 397,881 UK Biobank participants. An IC deficit composite score was constructed based on six IC components. Cox proportional hazards models were utilized to estimate the associations of IC deficit scores and individual IC components with the risk of glaucoma. We tested gene-IC interactions using polygenic risk score (PRS) data for glaucoma. Results: During a median follow-up time of 13.8 years, 6264 glaucoma cases were identified, encompassing 1661 cases of primary open-angle glaucoma (POAG). After adjustments for glaucoma PRS and conventional risk factors, each 1-point increase in IC score was associated with a 12% higher glaucoma risk (hazard ratio [HR] = 1.12, 95% confidence interval [CI] = 1.09-1.14). Participants with no less than 4 IC deficits had a 65% increased risk compared with those with no deficits (HR = 1.65, 95% CI = 1.43-1.90). Evidence of interaction between IC and glaucoma PRS was observed on the multiplicative scale, whereas no significant interaction was found on the additive scale. Population attributable fraction (PAF) analysis suggested that 12.0% of glaucoma cases could be prevented if all individuals maintained optimal IC. Conclusions: Impaired IC is significantly associated with an elevated risk of developing glaucoma, highlighting the value of nurturing and maintaining IC in preventing glaucoma. Translational Relevance: Our findings suggest that assessing and maintaining IC may serve as a practical strategy for early identification and prevention of glaucoma in clinical and population health settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.